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Abstract
Background: The prevalence of high resolution profiling of genomes has created a need for the
integrative analysis of information generated from multiple methodologies and platforms. Although
the majority of data in the public domain are gene expression profiles, and expression analysis
software are available, the increase of array CGH studies has enabled integration of high
throughput genomic and gene expression datasets. However, tools for direct mining and analysis
of array CGH data are limited. Hence, there is a great need for analytical and display software
tailored to cross platform integrative analysis of cancer genomes.
Results: We have created a user-friendly java application to facilitate sophisticated visualization
and analysis such as cross-tumor and cross-platform comparisons. To demonstrate the utility of
this software, we assembled array CGH data representing Affymetrix SNP chip, Stanford cDNA
arrays and whole genome tiling path array platforms for cross comparison. This cancer genome
database contains 267 profiles from commonly used cancer cell lines representing 14 different
tissue types.
Conclusion: In this study we have developed an application for the visualization and analysis of
data from high resolution array CGH platforms that can be adapted for analysis of multiple types
of high throughput genomic datasets. Furthermore, we invite researchers using array CGH
technology to deposit both their raw and processed data, as this will be a continually expanding
database of cancer genomes. This publicly available resource, the System for Integrative Genomic
Microarray Analysis (SIGMA) of cancer genomes, can be accessed at http://sigma.bccrc.ca.
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Background
Array comparative genomic hybridization (CGH) is a
method used to detect segmental DNA copy number alter-
ations and is widely used to discover chromosomal aber-
rations in cancer and other genetic diseases [1,2]. In this
method, differentially labeled genomic DNA samples are
competitively hybridized to chromosomal targets, and the
copy number balance between the two samples is
reflected by their signal intensity ratio. Numerous array
CGH platforms exist; these vary in the type of elements
present on the array and their corresponding coverage of
the human genome. With the development of high reso-
lution, genome wide arrays, tens of thousands of loci can
be evaluated for copy number status, facilitating the high
throughput search for genes potentially involved in
pathogenesis. This has allowed the identification of dis-
crete regions of alteration that may have been missed by
traditional cytogenetic methods and has proven to be a
useful platform for exploring the underlying genetic basis
of cancer [1,3].
With the increasing utilization of array CGH, it has not
only become important to establish standards for data
deposition, but to develop tools to facilitate public access
and to ease mining of available data. Currently, the
National Center for Biotechnology Information (NCBI) Gene
Expression Omnibus (GEO) repository [4] and European
Bioinformatics Institute (EBI) ArrayExpress [5] provide stor-
age for array CGH data, but these databases have been
largely designed for gene expression microarrays.
Although these sites support visualization of previously
analyzed gene expression profiles, there are limited tools
available for direct mining and analysis of array CGH
data. Hence, there is a need for forums specific to array
CGH data. Recently, attempts have been made in making
a database primarily of lower resolution array CGH data
[6]. However, with the accumulation of high density array
data generated with diverse technology, the viewing of
array data has become a bioinformatics challenge, espe-
cially when the integration of multiple datasets from dif-
ferent platforms is required. Therefore, a central database
with analytical software tailored specifically for analyzing
and visualizing different types of high resolution array
CGH data would greatly facilitate data mining.
In this study we have created a database consisting of
high-resolution, whole-genome array CGH profiles for
nearly 200 commonly used cancer cell lines profiled on
four different array platforms, which have been instru-
mental in biochemical and pharmacogenetic studies.
Moreover, we have developed a user friendly, web-based
java application called the System for Integrative Genomic
Microarray Analysis (SIGMA) for comparative analysis of
multiple genomes.
Results and Discussion
Cell-line collection
We have assembled a collection of 267 array CGH pro-
files, representing 184 distinct cell lines profiled on at
least one of the four array CGH platforms (Table 1, Table
2). Moreover, 14 different cancer tissue origins and 30 dis-
tinct cancer types are represented in this database, result-
ing in the assembly of a wide spectrum of genomes in this
repository (Table 2) [see Additional file 1]. Significantly,
56 of the 267 CGH profiles are unpublished raw data
which is now made public.
Main functionalities of SIGMA
In order to increase the utility of this collection, a signifi-
cant component of SIGMA is the web-based application
which allows for the user-friendly mining of this dataset.
Four major types of functionalities are offered by SIGMA:
(1) interrogation of a single sample, (2) visualization and
analysis of a single group of samples, (3) comparative
analysis of two groups of samples, and (4) integration of
data from multiple platforms (Figure 1B).
Visualization and interrogation of a single genome
The first function we discuss is the ability to view a single
high resolution array CGH profile at multiple magnifica-
tion levels. The major utility of this function is to display
the underlying genomic architecture of a cell line, so that
genetic features can be considered in experimental inter-
pretation. For example, a whole genome karyogram of
lung adenocarcinoma cell line H2087 profiled on the
SMRT array platform (Figure 2A). From this image, we see
many changes such as the loss of the 3p arm as well as seg-
mental changes in chromosomes 8, 19 and 20. Specifi-
cally, we can select chromosome 8 (Figure 2B) and view
that separately, then zoom into the region of interest and
visualize it in finer detail (Figure 2C). Users can then high-
light or place boundary lines in this region and query for
which genes are located within the region of interest.
Subsequently, using the interval search option, users can
retrieve the genes which are located in a desired region
and have the option to query commonly used biological
databases such as NCBI MIM, NCBI Gene, NCBI PubMed
and the UCSC Genome Browser. For example, if we look at
band 8q24.21 (Figure 2D), we can highlight the region
and search the interval for which genes it contains. When
we invoke the region search and retrieve only genes
curated by RefSeq, we see there are 8 genes in the ampli-
con. If the user selects a particular gene, options to link
out to the above mentioned biological databases become
available. The utility of this function is to facilitate a direct
connection from experimental findings to known, rele-
vant information. Moreover, the ability to interrogate for
specific genes and regions can be done for any types of the
analysis outlined (Figure 1B).BMC Genomics 2006, 7:324 http://www.biomedcentral.com/1471-2164/7/324
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Multiple genome comparison and mining across tumor 
types
A common research question is to look across a series of
samples with common phenotype to identify recurrent
genetic changes, for example comparison of lung adeno-
carcinomas [see Additional file 2]. With the spectrum of
samples warehoused in SIGMA, such a query can be per-
formed across multiple cancer types. For example, the
alignment of a set of samples representing 8 different can-
cer types revealed common amplification of the MYC
oncogene locus (Figure 3A), while the epidermal growth
factor receptor (EGFR) locus is amplified only in a subset
of samples (Figure 3B).
Recurrent alterations detected in one group of samples
can be compared against those in another group, for
example, the comparison of lung squamous cell carci-
noma (SqCC) with cervical SqCC [see Additional file 3].
The strategy for comparison, for example the overlay of
frequency plots derived from two groups of profiles, has
been described elsewhere [7,8].
Simultaneous visualization of data from multiple 
platforms
Cross platform comparison is essential to the multi-
dimensional descriptions of a genome. Here, we have
included a feature in SIGMA to allow users to view multi-
Table 2: Breakdown of cell lines based on tissue and array platform
Tissue type Distinct Cell 
Lines
Total 
Number
BCCRC 
SMRT
BCCRC 
MEDIP
Affymetrix 
100K
Affymetrix 
10K
Stanford 
cDNA
Lung 74 123 54 2 36 7 24
Breast 22 37 17 0 7 11 2
C o l o n 8920700
Lymphoma 10 10 9 0 1 0 0
L e u k e m i a 4620400
B r a i n / C N S 6600600
Lymphoblast1 20 31 16 0 0 15 0
K i d n e y 7700700
S k i n 1 1 1 2 40800
C e r v i x 8880000
O v a r y 7820600
P r o s t a t e 3530200
L i v e r 1110000
B o n e 2220000
B o n e  M a r r o w 1210100
Grand Totals 184 267 121 2 85 33 26
1Normal lymphoblast lines derived from patients with tumors
Table 1: Breakdown of cell line sources by tumor type and study
Tissue origin Reference # of 
samples
Array Platform PubMed 
ID
Data Deposited 
Online?
Location
Mantle cell lymphoma de Leeuw et al. (2004) 8 SMRT Array 15229187 Yes bccrc.ca/images/cg/
wanlam_mcl_sd.txt
Non-small cell lung cancer Garnis et al. (2006) 28 SMRT Array 16187286 Yes GEO: GSE2922
Small cell lung cancer, 
Lymphoblast
Coe et al.(2006a) 21 SMRT Array 16130125 No This study2
Breast Cancer Shadeo et al. (2006) 7 SMRT Array 16417655 Yes GEO: GSE3106
NCI-60 panel1 Garraway et al. (2005) 58 Affymetrix 100K SNP 
Array
16001072 Yes GEO: GSE2520
Small cell lung cancer, Breast 
cancer, Lymphoblast
Zhao et al. (2004) 33 Affymetrix 10K SNP Array 15126342 Yes research.dfci.harvard.edu/
meyersonlab/snp/cellFile/
Non-small cell lung cancer Zhao et al. (2005) 27 Affymetrix 100K SNP 
Array
15994928 Yes research2.dfci.harvard.edu/dfci/
snp/
Small cell lung cancer Kim et al. (2006) 24 Stanford cDNA Array 16116477 Yes genome-www5.stanford.edu/
Breast cancer Bredel et al. (2005) 2 Stanford cDNA Array 15858140 Yes genome-www5.stanford.edu/
Non-small cell lung cancer Wilson et al. (2006) 2 MeDIP Array 16397413 No This study2
Osteosarcoma Lim et al. (2004) 1 SMRT Array 15660435 No This study2
Assorted3 - 56 SMRT Array - - This study2
1NCI-60 panel includes 58 of the 60 total cell lines.
2This study refers to previously unavailable data now publicly available in SIGMA
3Assorted tumor types including: Non-small cell lung cancer, small cell lung cancer, osteosarcoma, melanoma, hepatocellular carcinoma, cervical 
cancer, breast cancer, ovarian cancer, leukemia, and multiple myelomaBMC Genomics 2006, 7:324 http://www.biomedcentral.com/1471-2164/7/324
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ple platforms of data simultaneously. We use the breast
cancer cell line, MCF7, to illustrate this functionality. Data
from four different array CGH platforms were available
publicly: SMRT array, Stanford cDNA microarray, Affyme-
trix 10K SNP array and the Affymetrix 100K SNP array.
Figure 4A illustrates the cross platform display of chromo-
some 17, while Figure 4B shows the variable density of
coverage by these four commonly used platforms.
(A) Schematic of the basic architecture of SIGMA Figure 1
(A) Schematic of the basic architecture of SIGMA. Java WebStart technology was utilized to develop the main user interface to 
the database, ensuring users will be running the latest version of the program. The application is connected to the MySQL data-
base through a JDBC driver provided by MySQL, over an Apache Web Server. (B) Outline of the various functionalities of 
SIGMA, with the five main types of visualization and analysis along with their associated uses.BMC Genomics 2006, 7:324 http://www.biomedcentral.com/1471-2164/7/324
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Integrative visualization of DNA copy number and 
methylation
One of the novel features we have provided is the integra-
tive visualization of copy number alterations with DNA
methylation status. The major premise in studying copy
number alterations at the DNA level is that these are the
primary changes involved in driving changes in gene
expression. Though gene dosage variation may be respon-
(A) Whole genome karyogram of the H2087 lung adenocarcinoma cell line profiled on the SMRT array using the May 2004  genomic build Figure 2
(A) Whole genome karyogram of the H2087 lung adenocarcinoma cell line profiled on the SMRT array using the May 2004 
genomic build. For each chromosome, there is a ratio plot associated with plotting the log2 ratio of the genomic element vs. 
the position of the element on the chromosome. The log2 ratio of the data point is calculated against a normal reference where 
positive ratios represent increased content and negative ratios represent decreased content in the tumor compared to the 
normal. (B) The first level of zoom to view a particular chromosome, in this case, chromosome 8. (C) 32X zoom into the ampli-
con at chromosome band 8q24.21. (D) The ability to link out to biological databases such as NCBI MIM, UCSC Genome Browser, 
NCBI Gene and NCBI PubMed with a gene of interest.BMC Genomics 2006, 7:324 http://www.biomedcentral.com/1471-2164/7/324
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sible for expression changes, alteration in DNA methyla-
tion pattern also contributes significantly to regulating
gene expression. Recently, methods for global methyla-
tion analysis to measure aberrant DNA methylation status
across tumor genomes have been developed [9-12]. Wil-
son et al (2006) compared methylation patterns with copy
number profiles in lung cancer cells. Utilizing genomic
and epigenetic data from this study for the H1395 lung
cancer cell line, we illustrate a parallel display in SIGMA.
Figure 5 shows a large segmental copy number gain span-
ning 1q21.2 to 1q23.1 with corresponding hypomethyla-
tion, localized precisely to 1q21.3 [13]. Significantly, both
copy number gain and decreased methylation can elevate
gene expression. The S100 calcium binding protein A10
(S100A10) gene within this region has been previously
shown to be over-expressed in lung cancer [14]. It is read-
ily apparent of the value of integrative studies examining
aberrant DNA methylation and genomic copy number.
With increased prevalence of studies of whole genome
methylation, this feature will be of greater importance.
Conclusion
We have developed an application for the integrative cross
platform analysis of array CGH data. The SIGMA applica-
tion facilitates consolidation and structuring of diverse
sources of array CGH data into a repository that is accessi-
ble with a new easy-to-use built-in web-based analytical
application. The launch version contains data for 267
array CGH profiles, representing cancer cell lines of over
14 different types of tissue. The ability of SIGMA to incor-
porate multiple array CGH platforms facilitates the
archiving of array CGH data from future publications,
regardless of current or future array platform used.
Though currently SIGMA's architecture facilitates the
direct mining of genomic and epigenomic data, this can
be easily adapted, and not limited to, high resolution
genetic and gene expression surveys.
Serial view of 8 samples representing 8 different tumor types, demonstrating the breadth of data available Figure 3
Serial view of 8 samples representing 8 different tumor types, demonstrating the breadth of data available. From left to right: 
HL60, HT29, HCC2279, HCC1143, HBL2, PC3, HeLa and A2058. (A) Chromosome 8, highlighting the amplification of the MYC 
oncogene, which appears to be amplified in all 8 tumor types. (B) Chromosome 7, highlighting the EGFR locus, where it appears 
that the lung cancer line (HCC2279) and the breast cancer line (HCC1143) harbor the amplification of this gene. Vertical lines 
denote log2 signal ratios from -1 to +1 with copy number increases to the right and decreases to the left of 0. Each black dot 
represents a single BAC clone.BMC Genomics 2006, 7:324 http://www.biomedcentral.com/1471-2164/7/324
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(A) Visualization of chromosome 17 of the breast cancer cell line MCF7 across multiple array CGH platforms using the May  2004 genomic build Figure 4
(A) Visualization of chromosome 17 of the breast cancer cell line MCF7 across multiple array CGH platforms using the May 
2004 genomic build. The four platforms are labeled above each ratio plot. The architecture of the chromosome is consistent 
across all four platforms, with the altered region highlighted in yellow seen clearly across 3 of the 4 platforms. (B) Visualization 
of chromosome 16 of the same breast cancer cell line, illustrating decreased density of markers in 3 of the 4 array platforms, 
with the SMRT array providing greater coverage to a region centromeric to band 16p13.11.BMC Genomics 2006, 7:324 http://www.biomedcentral.com/1471-2164/7/324
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Methods
Sources of raw array CGH data
The raw data for 267 CGH profiles in the database was
obtained from a variety of sources. They include both
published and unpublished data [7,8,15-22]. Publicly
available data were downloaded from NCBI GEO [4],
Stanford Microarray Database [23] or websites affiliated
with the author's laboratory. Data which were not pub-
licly available were obtained by consent from the authors
of the respective studies. The four array CGH platforms
used for this study were the whole genome tiling path
BAC (SMRT) array [24], the early access Affymetrix SNP
100 K array [16,20], the Stanford cDNA microarray [22]
and the Affymetrix SNP 10 K array [15]. In addition, 2 of
the cell lines were profiled for whole genome DNA meth-
ylation status using MeDIP array CGH [10,13]. For this
Integration of genomic and epigenetic profiles of the H1395 lung cancer cell line Figure 5
Integration of genomic and epigenetic profiles of the H1395 lung cancer cell line. (A) The genomic profile of H1395 is repre-
sented by a moving average spline of the data points. (B) Similarly, the epigenetic profile represents a residual plot of the tumor 
cell line subtracting the matching blood lymphocyte profile (BL1395), with a moving average spline representing the data points. 
The moving average was done at 1 MB intervals at increments of 200 kb for both profiles. Specifically, chromosomal region 
1q21.3 is highlighted illustrating a region of both copy number increase and hypomethylation.BMC Genomics 2006, 7:324 http://www.biomedcentral.com/1471-2164/7/324
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launch version, we concentrated on available cell lines
profiled on high density array platforms and did not
include profiles from clinical specimens. A summary of
the sources for the raw data is given in Table 1, while the
detailed description of each of the cell lines in the collec-
tion is given in Additional file 1.
Application layout of SIGMA
There are three main components which comprise this
application; a Java WebStart application interface allowing
users to formulate queries and perform visualization, an
Apache Web Service which facilitates the connection of
the user application to the database and a relational data-
base which is implemented using MySQL (Figure 1A). Uti-
lization of the Java WebStart technology ensures that users
will have the latest version of the application, without the
need for manual updating. In addition, efficiency and
speed of the application will largely be determined by the
user's computer specifications. Hence, we have provided
different versions of our application based on system
resource utilization, allowing users with greater system
resources to perform more analytical tasks per session.
Database implementation and structure
SIGMA is a continually expanding database of array CGH
experiments. The launch version contains 267 genomic
profiles generated from cancer cell lines, implemented
using the MySQL  relational database application. Each
array CGH experiment is contained in a separate database
table allowing for easy and seamless expansion of this
database. Upon addition of a new profile, a database table
which contains the information of each array CGH exper-
iment is updated. This table stores a record of each exper-
iment, with the name of the cell line, the American Type
Culture Collection (ATCC) identification (if applicable),
array platform used and the description of the cancer type
as part of the schema. For two channel array-based pro-
files, the dye which was used to label the sample is also
recorded. Lastly, mapping information pertaining to a
clone or probe and its position in the genome is kept in
file with a fixed format, such that subsequent improve-
ments and updates to the genomic positioning of the
array elements can be easily incorporated. Moreover, since
individual microarray software platforms use their own
map version, map information for all platforms were
compiled based on data from the UCSC Genome Browser
[25]. Currently, two genomic builds are supported: April
2003 (hg15) and May 2004 (hg17) assemblies.
Data processing
Data for each platform were processed as similarly as pos-
sible. SMRT array data were normalized using the stepwise
framework for normalization with default parameters
[26]. Similarly, Affymetrix 10 K and Affymetrix 100 K data
were normalized and processed using dChip  [27] with
default settings. Specifically, the samples from the Affyme-
trix 10 K dataset of lung cancer cell lines were referenced
against the group of matching blood lymphoblast lines
and similarly, the breast cancer cell lines were referenced
against their matching blood lymphoblast lines. Affyme-
trix 100 K data from Zhao et al. (2004) were referenced
against 12 normal individuals and the NCI-60 profiles
were referenced against 6 normal diploid controls. The
gender of the profiles were not specified, hence data from
the X chromosome may not be an accurate reflection. Seg-
mentation of all data was performed using aCGH-Smooth
[28], with data for the sex chromosomes removed prior to
segmentation – as profiles were generated with sex
matched or mismatched reference DNA in two channel
hybridization experiments – and run with the settings of
Lambda = 6.75 and "breakpoints per chromosome" =
100. Each element of the array is given a call with respect
to normal: -1 if the element shows copy loss, 0 if the ele-
ment shows no change in copy number and +1 if the ele-
ment shows increased genomic content.
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